Optimizing the clinical utility of biomarkers in oncology: The NCCN biomarkers compendium

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 5, 2015, Pages 608-611

  Birkeland, Marian L ^a   McClure, Joan S ^a  

^a NCCN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

HUMAN; ONCOLOGY; PRACTICE GUIDELINE; STANDARDS;

HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84928963627     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2014-0146-RA     Document Type: Short Survey

References (3)

1. Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol. 2011;29(2):186-191. doi: 10.1200/JCO.2010.31.6414.
2. National Comprehensive Cancer Network (NCCN). Development and update of the NCCN guidelines. http://www.nccn.org/professionals/physician-gls/guidelines-development.asp. Accessed February 21. 2014.
3. National Comprehensive Cancer Network (NCCN). The NCCN Biomarkers Compendium (NCCN Compendium). http://www.nccn.org/professionals/biomarkers/content/. Accessed February 14, 2014.